US company NorthWest
Biotherapeutics has been allowed
to sell its brain cancer drug in
Germany, before the treatment had
finished its late-stage trial.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 11 Mar 14 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Mar 14
GLAXOSMITHKLINE says it “responded proactively” when ACCC concerns were raised about the packaging of its Voltaren pain relief products, after a Federal Court decision which accepted admissions that the company had breached Australian Consumer Law (PD breaking news Fri) in the marketing of Osteo Gel and Emulgel over a five year period between 2012 and 2017.